PL-100
PL-100 is a potent HIV-1 protease inhibitor with a Ki of 36 pM and an EC50 of 16 nM. PL-100 inhibits viral replication by suppressing HIV-1 protease activity and demonstrates excellent antiviral efficacy against drug-resistant HIV strains. PL-100 can be used in research on drug-resistant HIV disease[1].
Product Specifications
CAS Number
612547-11-2
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
HIV Protease
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/pl-100.html
Smiles
O=S(N(CC(C)C)[C@H](CO)CCCCNC([C@@H](NC(OC)=O)C(C1=CC=CC=C1)C2=CC=CC=C2)=O)(C3=CC=C(C=C3)N)=O
Molecular Formula
C33H44N4O6S
Molecular Weight
624.79
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
TCF19, Control Peptide (Transcription Factor 19, TCF-19, SC1, SC1-1, Transcription Factor SC1)
Leukocyte Cell Derived Chemotaxin 1 (LECT1), Recombinant, Human, His-Tag, T7-Tag